Polymer Nanoparticles—Promising Carriers for Drug Delivery
A special issue of Pharmaceutics (ISSN 1999-4923). This special issue belongs to the section "Drug Delivery and Controlled Release".
Deadline for manuscript submissions: closed (31 August 2023) | Viewed by 130
Special Issue Editors
2. Key Laboratory of Forest Plant Ecology, Ministry of Education, Northeast Forestry University, Harbin 150040, China
3. Heilongjiang Provincial Key Laboratory of Ecological Utilization of Forestry-Based Active Substances, Northeast Forestry University, Harbin 150040, China
Interests: pharmaceutical chemistry; natural products; drug crystals; nanomedicine
Special Issues, Collections and Topics in MDPI journals
2. Key Laboratory of Forest Plant Ecology, Ministry of Education, Northeast Forestry University, Harbin 150040, China
3. Heilongjiang Provincial Key Laboratory of Ecological Utilization of Forestry-Based Active Substances, Northeast Forestry University, Harbin 150040, China
Interests: pharmaceutical chemistry; natural products; nanomedicine
2. Key Laboratory of Forest Plant Ecology, Ministry of Education, Northeast Forestry University, Harbin 150040, China
3. Heilongjiang Provincial Key Laboratory of Ecological Utilization of Forestry-Based Active Substances, Northeast Forestry University, Harbin 150040, China
Interests: pharmaceutical chemistry; natural products; nanomedicine
Special Issue Information
Dear Colleagues,
Recent advances in nanotechnology sciences has led to the development of new treatment approaches for various diseases such as cancer. Nanotechnology advances can potentially minimize the side effects of drugs through the employment of effective and controlled drug delivery systems (DDSs). Polymers are optimal tools providing drug delivery mechanisms through the unique features of pharmacokinetics, circulation time, biocompatibility, and biodegradability. Nanocarriers based on polymers (synthetic, semi-synthetic or natural) are currently attracting much attention to perform efficient drug delivery, especially in cancer therapy.
Over the last few decades, different kinds of polymer nanoparticulate (PNPs) systems have been developed (e.g., simple, stealth, targeted, stimuli-responsive and prodrug) to overcome the limitations of free therapeutics and navigate biological barriers and cells that are heterogeneous across patient populations and diseases and as lipid-based, polymeric, and inorganic nanoparticles are engineered in increasingly specified ways.
The natural or synthetic polymers have various biomedical applications due to their unique characteristics such as physical flexibility, chemical features, proper surface properties, hydrogelability, biocompatibility, biodegradability, porosity, mechanical strength, and hydrophobicity or amphibianity.
PNPs can be used to improve the therapeutic performance of anticancer drugs with more influential roles in therapeutic procedures than conventional chemotherapy or conventional medications. PNPs not only reduce the toxicity of chemotherapy drugs to healthy tissues adjacent to the tumor, but can also improve the solubility of these agents.
The journal Pharmaceuticals invites scientists to submit original papers or reviews, which will be published in a Special Issue on “Polymer Nanoparticles- Promising Carriers for Drug Delivery”. This Special Issue aims to collect the following related topics: polymer nanoparticles, drug delivery systems, pharmaceutical chemistry, tumor penetration, and synthetic, semi-synthetic or natural agents.
Prof. Dr. Xiuhua Zhao
Dr. Dongmei Zhao
Dr. Shougang Jiang
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceutics is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- polymer nanoparticles
- drug delivery systems
- pharmaceutical chemistry
- anticancer therapy
- immunotherapy
